Clinical Trial Update: FACE Phase II (a Stage II Trial) [Phase 1, Phase 2]

View source ↗

Summary

Stanford University is conducting the FACE Phase II trial, a combined Phase 1/Phase 2 study currently recruiting participants to evaluate cognitive disorders in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behavioral Impairment
• Cognitive Impairment
• Subjective Cognitive Decline

Snippet

Sponsor: Stanford University | Conditions: MCI, Subjective Cognitive Decline (SCD) | Phase 1, Phase 2 | Status: RECRUITING